Sujal Desai
Overview
Explore the profile of Sujal Desai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hannah J, Rodziewicz M, Mehta P, Heenan K, Ball E, Barratt S, et al.
Rheumatol Adv Pract
. 2024 May;
8(2):rkae056.
PMID: 38765189
Interstitial lung disease (ILD) is a significant complication of many systemic autoimmune rheumatic diseases (SARDs), although the clinical presentation, severity and outlook may vary widely between individuals. Despite the prevalence,...
2.
Margaritopoulos G, Proklou A, Trachalaki A, Badenes Bonet D, Kokosi M, Kouranos V, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38348245
Background: Overnight desaturation predicts poor prognosis across interstitial lung diseases (ILDs). The aim of the present study was to investigate whether nocturnal desaturation is associated with pulmonary vasculopathy and mortality....
3.
Hunter B, Argyros C, Inglese M, Linton-Reid K, Pulzato I, Nicholson A, et al.
Br J Cancer
. 2023 Nov;
129(12):1949-1955.
PMID: 37932513
Background: Methods to improve stratification of small (≤15 mm) lung nodules are needed. We aimed to develop a radiomics model to assist lung cancer diagnosis. Methods: Patients were retrospectively identified...
4.
Garfield B, Bianchi P, Arachchillage D, Caetano F, Desai S, Doyle J, et al.
Crit Care Med
. 2023 Jun;
51(8):1064-1073.
PMID: 37276353
Objectives: Early studies of venovenous extracorporeal membrane oxygenation (ECMO) in COVID-19 have revealed similar outcomes to historical cohorts. Changes in the disease and treatments have led to differences in the...
5.
Sheeka A, Singaravelou A, Bartlett E, Sivarasan N, Rawal B, Devaraj A, et al.
Br J Radiol
. 2022 Oct;
96(1141):20220191.
PMID: 36193768
Objectives: To compare the experience of COVID-protected and mixed cohort pathways in COVID-19 transmission at a tertiary referral hospital for elective CT-guided lung biopsy and ablation during the COVID-19 pandemic....
6.
Singh S, Gorog D, Mahon C, Rawal B, Semple T, Nicol E, et al.
Crit Care Med
. 2021 Aug;
49(11):e1190-e1191.
PMID: 34369426
No abstract available.
7.
Martinelli A, Ingle T, Newman J, Nadeem I, Jackson K, Lane N, et al.
Eur Respir J
. 2020 Sep;
56(5).
PMID: 32907891
Introduction: Pneumothorax and pneumomediastinum have both been noted to complicate cases of coronavirus disease 2019 (COVID-19) requiring hospital admission. We report the largest case series yet described of patients with...
8.
Jacob J, Odink A, Brun A, Macaluso C, De Lauretis A, Kokosi M, et al.
Respir Med
. 2018 May;
138:95-101.
PMID: 29724400
Background: Pleuroparenchymal fibroelastosis (PPFE) has been described in hypersensitivity pneumonitis (HP) yet its functional implications are unclear. Combined pulmonary fibrosis and emphysema (CPFE) has occasionally been described in never-smokers with...
9.
Jacob J, Bartholmai B, Rajagopalan S, van Moorsel C, van Es H, van Beek F, et al.
Am J Respir Crit Care Med
. 2018 Apr;
198(6):767-776.
PMID: 29684284
Rationale: Quantitative computed tomographic (CT) measures of baseline disease severity might identify patients with idiopathic pulmonary fibrosis (IPF) with an increased mortality risk. We evaluated whether quantitative CT variables could...
10.